This week, millions of NHS workers will strike once again as pay disputes between workers and the government rumbles on. On Tuesday 19th and Wednesday 20th of September, NHS consultants will be taking industrial action while from Wednesday to Friday, junior doctors will also be on strike.
According to a report by the Institute for Public Policy Research (IPPR) for its Commission on Health and Prosperity, long-term sickness has become a “serious fiscal threat” to the UK due to absences from work. The report argues that action is needed to reform health and social care and that there is the chance to deliver a once-in-a-generation NHS reform to restrain killer costs and end second-rate care.
Rishi Sunak is set to delay plans to ban conversion therapy in the UK following discussions around how the legislation would be worded have been left unresolved. The decision comes just a few months after ministers promised that a bill would be published to solve the issue in November.
Do It London, a campaign led by the London HIV Prevention Programme (LHPP) is marking this year’s Sexual Health Week (11-17 September) by teaming up
The Government has announced an extra £200m worth of funding to boost NHS resilience over winter. However, NHS leaders and trusts are warning that unless ministers focus on ending industrial action, the healthcare system will come under further pressure.
Councillors in London have asked the Government to introduce national smokefree conditions for pavement seating outside pubs, cafes and restaurants.
Yesterday, the Government launched its suicide prevention strategy for England which sets out a 5-year plan to prevent suicide and self harm. The Government is hoping to reduce suicide rates within 2.5 years of implementation.
Amid fears that children are increasingly using vapes and could become addicted, ministers are set to ban single-use vapes. The move could come as early as next week as the health department has decided that the products, which often come in colourful packaging and fruity flavours, are overwhelmingly aimed at people under the age of 18.
Eli Lilly’s diabetes drug Mounjaro has gained the backing of Britain’s healthcare cost-effectiveness watchdog, which said it would be a good option for patients with poorly controlled type 2 diabetes. The National Institute for Health and Care Excellence (NICE) said in draft final guidance that it estimates some 180,000 people could benefit from the new treatment.
As temperatures surge, with the heat health warning climbing from yellow to amber, concerns arise over the well-being of individuals living with dementia. Dehydration, a common challenge for those with memory issues, becomes a pressing issue during hot weather. Families and caregivers are urged to take precautions to ensure the safety and hydration of their loved ones.
In the final session of the second Dementia Commission inquiry, panellists gave evidence on ways to improve engagement and tackle stigma in dementia care. In
The second session of the dementia inquiry focused on improving population health through innovation, bringing the benefits of technology and AI to reshape dementia care.
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.